The highly sensitized, high MELD, simultaneous liver-kidney or status 1A heart-liver transplant candidate.
作者信息
Taner Timucin
机构信息
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA. E-mail:
出版信息
Clin Liver Dis (Hoboken). 2017 Feb 3;9(1):18-20. doi: 10.1002/cld.608. eCollection 2017 Jan.
Abstract
摘要
相似文献
1
The highly sensitized, high MELD, simultaneous liver-kidney or status 1A heart-liver transplant candidate.高致敏、高终末期肝病模型（MELD）评分、肝肾联合移植或1A状态的心肝联合移植候选者。
Clin Liver Dis (Hoboken). 2017 Feb 3;9(1):18-20. doi: 10.1002/cld.608. eCollection 2017 Jan.
2
Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.所有状态 1A 患者都应优先于高 MELD 患者吗？极危重肝移植受者的风险分层概念。
Transplantation. 2019 Oct;103(10):2121-2129. doi: 10.1097/TP.0000000000002651.
3
Differential Simultaneous Liver and Kidney Transplant Benefit Based on Severity of Liver Damage at the Time of Transplantation.基于移植时肝损伤严重程度的肝肾联合移植差异获益情况
Gastroenterology Res. 2017 Apr;10(2):106-115. doi: 10.14740/gr803w. Epub 2017 Apr 19.
4
Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients.慢性肝衰竭失代偿期 3 级患者的 14 天等待名单死亡率高于状态 1a 患者。
Hepatology. 2019 Jul;70(1):334-345. doi: 10.1002/hep.30624. Epub 2019 May 17.
5
End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.终末期肝病模型（MELD）评分>40的终末期肝病患者与1A类患者相比，等待名单上的死亡率更高。
Hepatol Int. 2016 Sep;10(5):838-46. doi: 10.1007/s12072-016-9735-4. Epub 2016 May 24.
6
Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.MELD-XI 评分排除国际标准化比值模型预测心脏移植结局：来自器官共享联合网络登记处的证据。
J Heart Lung Transplant. 2016 Feb;35(2):222-7. doi: 10.1016/j.healun.2015.10.008. Epub 2015 Oct 9.
7
Approach to the Highly Sensitized Kidney Transplant Candidate.高度致敏肾移植受者的处理方法
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):684-93. doi: 10.2215/CJN.05930615. Epub 2016 Feb 25.
8
Liver-kidney transplantation in the Model for Endstage Liver Disease era: is it overdone?终末期肝病模型时代的肝肾联合移植：是否过度开展了？
Curr Opin Organ Transplant. 2007 Jun;12(3):245-252. doi: 10.1097/MOT.0b013e32814f1c7d.
9
MELD Stratified Outcomes Among Recipients With Diabetes or Hypertension: Simultaneous Liver Kidney Versus Liver Alone.糖尿病或高血压患者中MELD分层的结局：肝肾联合移植与单纯肝移植对比
J Clin Gastroenterol. 2018 Jan;52(1):67-72. doi: 10.1097/MCG.0000000000000818.
10
The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate.伴有急性肾功能不全的肝移植受者：单中心对肝肾联合移植候选者的评估
Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13148. Epub 2017 Nov 24.
本文引用的文献
1
Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation.肝移植为心脏-肝联合移植中的心脏移植物提供免疫保护。
Am J Transplant. 2016 Dec;16(12):3522-3531. doi: 10.1111/ajt.13870. Epub 2016 Jun 24.
2
Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation.在肝肾联合移植后，肾脏的慢性细胞和抗体介导的损伤减少。
Kidney Int. 2016 Apr;89(4):909-17. doi: 10.1016/j.kint.2015.10.016. Epub 2016 Jan 23.
3
Functional Immune Anatomy of the Liver-As an Allograft.肝脏作为同种异体移植的功能性免疫解剖学
Am J Transplant. 2016 Jun;16(6):1653-80. doi: 10.1111/ajt.13749. Epub 2016 Mar 21.
4
ABO-compatible liver allograft antibody-mediated rejection: an update.ABO相容肝移植抗体介导的排斥反应：最新进展
Curr Opin Organ Transplant. 2015 Jun;20(3):314-24. doi: 10.1097/MOT.0000000000000194.
5
Antibody-mediated rejection in liver transplantation: current controversies and future directions.肝移植中抗体介导的排斥反应：当前争议与未来方向
Liver Transpl. 2014 May;20(5):514-27. doi: 10.1002/lt.23826. Epub 2014 Feb 25.
6
Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival.
Transplantation. 1995 Mar 27;59(6):919-21.
Zotero 插件